SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Cardinal Health Inc. 
 OH
  SEC # 721371


        
1  Related Registrant:   

    Click to view...      Registrant      About      Filings      Files      Relationships      Names    
  Topics  
    Web       

252  Topics
Topic emoji
 within the 

Show:   Most-Recent Document   All Documents   And:   Exhibits  

 As Of  Filing  Doc.  Page    Title Docs.
  In ascending order
2/16/24424B51About This Prospectus
1About This Prospectus Supplement
9/27/23DEF 14A1About Us
1Advisory Vote on the Frequency of Future Advisory Votes to Approve the Compensation of Our Named Executive Officers
1Advisory Vote to Approve the Compensation of Our Named Executive Officers
1Agreement with Elliott
1All Other Compensation
8/15/2310-K1And Corporate Governance
9/27/23DEF 14A1Annex A: Use of Non -- Gaap Financial Measures
1Approach to ESG Topics
1Audit Committee Matters
1Audit Committee Report
1Back to Contents
1Beneficial Ownership
1Board Membership Criteria: What We Look For
8/15/2310-K1Business
2/16/24424B51Capitalization
1Cautionary Statement Regarding Forward-Looking Statements
9/27/23DEF 14A1Clawbacks
1Communicating with the Board
2/16/24424B51Company, The
9/27/23DEF 14A1Compensation Discussion and Analysis
1Compensation Philosophy and Practices
8/15/2310-K1Consolidated Balance Sheets at June 30, 2023 and 2022
1Consolidated Statements of Cash Flows for the Fiscal Years Ended June 30, 2023, 2022 and 2021
1Consolidated Statements of Comprehensive Income/(Loss) for the Fiscal Years Ended June 30, 2023, 2022 and 2021
1Consolidated Statements of Earnings/(Loss) for the Fiscal Years Ended June 30, 2023, 2022 and 2021
1Consolidated Statements of Shareholders' Equity/(Deficit) for the Fiscal Years Ended June 30, 2023, 2022 and 2021
2/1/2410-Q1Controls and Procedures
9/27/23DEF 14A1Corporate Governance
1Corporate Governance Documents
1Deferred Compensation
1Definitions
1Delinquent Section 16(a) Reports
2/16/24424B51Description of Capital Stock
9/27/23DEF 14A1Description of Compensation Actually Paid Versus Company Performance
2/16/24424B51Description of Debt Securities
1Description of the Notes
1Description of Units
9/27/23DEF 14A1Director Compensation
8/15/2310-K1Directors, Executive Officers
1Directors, Executive Officers and Corporate Governance
9/27/23DEF 14A1Election of Directors
1Elements of Compensation for Executive Officers
1Equity Compensation Plan Information
1Exclusions from Non-GAAP Financial Measures
1Executive Compensation
1Executive Compensation Governance Features
1Executive Compensation Tables
1Executive Summary
1Executives to Retain Significant Stock
2/1/2410-Q1Exhibits
8/15/2310-K1Exhibits, Financial Statement Schedules
2/16/24424B51Experts
2/1/2410-Q1Explanation and Reconciliation of Non-GAAP Financial Measures
9/27/23DEF 14A1Fees Paid to Ernst & Young LLP
2/1/2410-Q1Financial Statemen
1Financial Statements
8/15/2310-K1Financial Statements and Supplementary Data
9/27/23DEF 14A1Fiscal 2021-2023 Performance Share Unit Payouts
1Fiscal 2023 Annual Incentive Compensation
1Fiscal 2023 Base Salary
1Fiscal 2023 GAAP to Non-GAAP Reconciliations
1Fiscal 2023 Long-Term Incentive Targets and Grants
1Fiscal 2023 Performance
1Fiscal 2023-2025 Performance Share Unit Grants
8/15/2310-K1Form 10-K Cross Reference Index
2/1/2410-Q1Form 10-Q Cross Reference Index
9/27/23DEF 14A1Forward-Looking Statements
1Gaap Financial Measures
1General Information About the Annual Meeting
1Governance and Board Highlights
1Grants of Plan-Based Awards for Fiscal 2023
1How to Vote in Advance of the Annual Meeting
1Human Resources and Compensation Committee Report
1Incentive Plans
2/16/24424B51Incorporation of Certain Documents by Reference
1Information Concerning Forward-Looking Statements
8/15/2310-K1Introduction
2/16/24424B51Legal Matters
2/1/2410-Q1Legal Proceedings
9/27/23DEF 14A1Letter to Cardinal Health Shareholders
2/1/2410-Q1Management's Discussion and Analysis of Financial Condition and Results of Operations
8/15/2310-K1Market for Registrant's Common Equity
1Market for Registrant's Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities
9/27/23DEF 14A1Most Important Performance Measures
1Nonqualified Deferred Compensation in Fiscal 2023
8/15/2310-K1Note 1
2/1/2410-Q1Note 10
8/15/2310-K1Note 11
2/1/2410-Q1Note 12
8/15/2310-K1Note 13
1Note 14
2/1/2410-Q1Note 2
8/15/2310-K1Note 3
2/1/2410-Q1Note 4
8/15/2310-K1Note 5
2/1/2410-Q1Note 6
1Note 7
8/15/2310-K1Note 8
1Note 9
1Notes 1
1Notes to Consolidated Financial Statements
6/23/2311-K1Notes to Financial Statements
9/27/23DEF 14A1Notice
8/15/2310-K1Of Independent Registered Public Accounting Firm
9/27/23DEF 14A1Option Exercises and Stock Vested for Fiscal 2023
1Other Elements of Compensation
2/1/2410-Q1Other Information
9/27/23DEF 14A1Other Matters
1Our 2023 Board Nominees
1Our Board's Composition and Structure
1Our Board's Primary Role and Responsibilities and Processes
1Our Director Nominees
1Our Policies, Guidelines, and Practices Related to Executive Compensation
1Outstanding Equity Awards at Fiscal Year-End for Fiscal 2023
1Pay Ratio Disclosure
1Pay Versus Performance
1Performance Measure Calculations
2/16/24424B51Plan of Distribution
9/27/23DEF 14A1Policy on Pre-Approval of Services Provided by Ernst & Young LLP
1Potential Payments upon Termination of Employment or Change of Control at Fiscal Year-End
8/15/2310-K1Properties
9/27/23DEF 14A1PROPOSAL 1 -- Election of Directors
1PROPOSAL 2 -- Ratification of Appointment of Ernst & Young LLP as Independent Auditor
1PROPOSAL 3 -- Advisory Vote to Approve the Compensation of Our Named Executive Officers
1PROPOSAL 4 -- Advisory Vote on the Frequency of Future Advisory Votes to Approve the Compensation of Our Named Executive Officers
1Proposal 5 -- Executives to Retain Significant Stock
1Proposal 6 -- Shareholder Ratification of Excessive Termination Pay
1Proxy Summary
2/1/2410-Q1Quantitative and Qualitative Disclosures about Market Risk
9/27/23DEF 14A1Ratification of Appointment of Ernst & Young LLP as Independent Auditor
1Related Person Transactions Policy and Process
8/15/2310-K1Report
6/23/2311-K1Report of Independent Registered Public Accounting Firm
8/15/2310-K1Reports
2/16/24424B51Risk Factors
9/27/23DEF 14A1Roadmap to Voting Matters
6/23/2311-K1Schedule H, Line 4i on Form 5500: Schedule of Assets (Held at End of Year)
8/15/2310-K1Schedule II -- Valuation and Qualifying Accounts
9/27/23DEF 14A1Share Ownership Information
1Shareholder Engagement
1Shareholder Engagement and Consideration of 2022 Say-on-Pay Vote
1Shareholder Proposals
1Shareholder Ratification of Excessive Termination Pay
1Shareholder Recommendations for Director Nominees
6/23/2311-K1Signature
2/1/2410-Q1Signatures
9/27/23DEF 14A1Standards of Business Conduct
6/23/2311-K1Statements of Changes in Net Assets Available for Benefits
1Statements of Net Assets Available for Benefits
9/27/23DEF 14A1Submitting Proxy Proposals and Director Nominations for the Next Annual Meeting of Shareholders
2/16/24424B51Summary
9/27/23DEF 14A1Summary Compensation Table
2/16/24424B51Table of Contents
1The Company
9/27/23DEF 14A1Transfer Agent
2/16/24424B51U.S. Federal Income Tax Considerations for Non-U.S. Holders
1Underwriting
5/4/2310-Q1Unregistered Sales of Equity Securities and Use of Proceeds
2/1/2410-Q1Unregistered Sales of Equity Securities, Use of Proceeds, and Issuer Purchases of Equity Securities
2/16/24424B51Use of Proceeds
1Validity of the Securities
8/15/2310-K1Valuation and Qualifying Accounts
9/27/23DEF 14A1Virtual Annual Meeting
2/16/24424B51Where You Can Find More Information And
1Where You Can Find More Information and Incorporation of Certain Documents by Reference

Top

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Sun., Apr. 28, 9:57:13.2pm ET